Sign in
4

Changes in Ownership

HERON THERAPEUTICS, INC. /DE/ Filed Acc 0001209191-23-004303

Options or other derivatives

  • Chief Executive Officer acquired 850,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Derivatives
Quart Barry D Chief Executive Officer 2023-01-18 Grant or award · Employee Stock Option (Right to Buy) +850,000 850,000 D
Loading xslF345X03/doc4.xml…